Medical Countermeasures Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever VirusGlobal Biodefense StaffJuly 3, 2025
Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
NIAID Awards Contract to Develop Treatments for Radiation Exposure Contracts + Grants October 26, 2015 …
CIDR-GSK Partnership Spotlights Antifolates for TB Drug Discovery Medical Countermeasures October 15, 2015 …
Bavarian Nordic Announces Start of EBOVAC-Salone Trial for Ebola Vaccine Biosecurity October 9, 2015 …
Positive Results for Arno Therapeutics’ Broad Spectrum Antimicrobial Biosecurity September 20, 2015 …
